Publicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (192)

2024

  1. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer

  2. Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort

    Gastroenterologia y Hepatologia

  3. Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

    British Journal of Surgery, Vol. 111, Núm. 1

  4. Feasibility and Short-Term Outcomes in Liver-First Approach: A Spanish Snapshot Study (the RENACI Project)

    Cancers, Vol. 16, Núm. 9

  5. Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease

    Human Pathology, Vol. 143, pp. 50-61

  6. LiverAI: New tool in the landscape for liver health

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 6, pp. 646-648

  7. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

  8. Real-life data of immune recovery using bictegravir/emtricitabine/ tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 3, pp. 595-607

  9. Sodium metabisulfite a current low relevant allergen in Spain

    Journal of the European Academy of Dermatology and Venereology

  10. Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry

    Cirugia Espanola

  11. Textbook outcomes in the liver-first approach for colorectal liver metastases: prospective multicentre analysis

    BJS Open, Vol. 8, Núm. 1

  12. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology

  13. Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP

    European Journal of Pediatrics

  14. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

    Pharmaceutics, Vol. 16, Núm. 5

  15. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia

2023

  1. Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  2. Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  3. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  4. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217

  5. Critical appraisal beyond clinical guidelines for intraabdominal candidiasis

    Critical Care, Vol. 27, Núm. 1